Skip to main content
. 2013 Sep;5(Suppl 4):S389–S396. doi: 10.3978/j.issn.2072-1439.2013.07.10

Table 7. Phase I/II studies of non-platinum doublets in advanced NSCLC (10).

Regimen Studies (n) Assessable patients (n)     RR (%) range AR MS (months) IYS (%)
Gem/VNR 6 286 19-73 41 9,12 NR
Doc/VNR 6 174 20-88 48 5,9 24
Pac/Gem 3 117 30-35 33 NR NR
Doc/Gem 2 73 38-39 13 51
Doc/CPT-11 1 32 34 9,8 38
Pac/VNR 1 25 16 NR NR
Gem/Topotecan 1 13 30 NR NR